FPCP
VANI icon

Fort Point Capital Partners’s Vivani Medical VANI Stock Holding History

Fort Point Capital Partners’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-417
Closed -$12K – 163
2017
Q3 		$12K Buy
+417
New +$11.7K 0.01% 136

Other funds holding VANI

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HSA
HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return

Fort Point Capital Partners's VANI Position: Q4 2017 in Review

Fort Point Capital Partners sold out of Vivani Medical (VANI) in Q4 2017, closing a stake of 417 shares — an estimated $12K sold.

Fort Point Capital Partners first reported a position in VANI in Q3 2017 and held it in 1 quarter. The position peaked at $12K in Q3 2017. 43 funds tracked by Wall St. Rank hold VANI as of Q4 2017.

  • Fort Point Capital Partners reported no remaining Vivani Medical position as of Q4 2017 after selling out during the quarter.
  • Fort Point Capital Partners sold 417 Vivani Medical shares in Q4 2017, an estimated $12K.
  • Fort Point Capital Partners first reported a position in Vivani Medical in Q3 2017 and held it in 1 quarter.
  • Fort Point Capital Partners's Vivani Medical position peaked at $12K in Q3 2017.
  • 43 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2017.

Based on Fort Point Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.